Opioid receptor and peptide gene polymorphisms: potential implications for addictions

Author： LaForge K.S.   Yuferov V.   Kreek M.J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.410, Iss.2, 2000-12, pp. : 249-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corrigendum to ''Opioid receptor and peptide gene polymorphisms: potential implications for addictions'' [Eur. J. Pharmacol. 410 (2001) 249-268]

By Steven LaForge K.   Yuferov V.   Kreek M.J.  

European Journal of Pharmacology, Vol. 426, Iss. 1, 2001-08 ,pp. : 145-145

Elsevier

Access to resources Recommend Favorite

Antiparkinson potential of -opioid receptor agonists

By Hudzik T.J.   Howell A.   Payza K.   Cross A.J.  

European Journal of Pharmacology, Vol. 396, Iss. 2, 2000-05 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite

Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies

By Labruijere Sieneke   Ibrahimi Khatera   Chan Kayi Y   MaassenVanDenBrink Antoinette  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1309-1323

Informa Healthcare

Access to resources Recommend Favorite

Non-peptide Opioid Receptor Ligands - Recent Advances. Part I - Agonists

By  

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1567-1589

Bentham Science Publishers

Access to resources Recommend Favorite

Non-peptide Opioid Receptor Ligands - Recent Advances. Part II - Antagonists

By  

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1591-1603

Bentham Science Publishers

Access to resources Recommend Favorite